4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0000950170-24-081594
Chief Business Officer sold 11,000 shares at $32.49 ($357,390)
- Chief Business Officer acquired 11,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Robb Gary Charles Chief Business Officer | 2024-07-01 | Option exercise 10b5-1 | +11,000 | $3.29 | $36,190 | 37,291 | D |
| Robb Gary Charles Chief Business Officer | 2024-07-01 | Sale 10b5-1 | −11,000 | $32.49 | $357,390 | 26,291 | D |
| Derivatives | |||||||
| Robb Gary Charles Chief Business Officer | 2024-07-01 | Option exercise · Stock option (right to buy) 10b5-1 | −11,000 | 25,037 | D | ||
| Open-market sales · 11,000 sh · avg $32.49 · $357,390 | |||||||
Loading xslF345X05/ownership.xml…